Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis o... von Lambertini, M., Ceppi, M., Poggio, F., Peccatori, F.A., Azim, H.A., Ugolini, D., Pronzato, P., Loibl, S., Moore, H.C.F., Partridge, A.H., Bruzzi, P., Del Mastro, L.

Volltext

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines von Aapro, M, Beguin, Y, Bokemeyer, C, Dicato, M, Gascón, P, Glaspy, J, Hofmann, A, Link, H, Littlewood, T, Ludwig, H, Österborg, A, Pronzato, P, Santini, V, Schrijvers, D, Stauder, R, Jordan, K, Herrstedt, J

Volltext

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines von Aapro, M, Beguin, Y, Bokemeyer, C, Dicato, M, Gascón, P, Glaspy, J, Hofmann, A, Link, H, Littlewood, T, Ludwig, H, Österborg, A, Pronzato, P, Santini, V, Schrijvers, D, Stauder, R, Jordan, K, Herrstedt, J

Volltext

HER2-positive metastatic breast cancer: A changing scenario von Mustacchi, G, Biganzoli, L, Pronzato, P, Montemurro, F, Dambrosio, M, Minelli, M, Molteni, L, Scaltriti, L

Volltext

The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors von Boutros, A., Carosio, R., Campanella, D., Spagnolo, F., Banelli, B., Morabito, A., Pistillo, M.P., Croce, E., Cecchi, F., Pronzato, P., Queirolo, P., Raposio, E., Fontana, V., Tanda, E.T.

Volltext

Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis von Aapro, M., Moebus, V., Nitz, U., O'Shaughnessy, J., Pronzato, P., Untch, M., Tomita, D., Bohac, C., Leyland-Jones, B.

Volltext

Corrections to “Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines” von Aapro, M., Beguin, Y., Bokemeyer, C., Dicato, M., Gascón, P., Glaspy, J., Hofmann, A., Link, H., Littlewood, T., Ludwig, H., Österborg, A., Pronzato, P., Santini, V., Schrijvers, D., Stauder, R., Jordan, K., Herrstedt, J.

Volltext

Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature von Boutros, A., Bottini, A., Rossi, G., Tanda, E.T., Spagnolo, F., Barletta, G., Croce, E., Fava, P., Parisi, A., De Rosa, F., Palla, M., Marconcini, R., Ferrari, M., Grandis, M., Spallarossa, P., Sarocchi, M., Arboscello, E., Del Mastro, L., Lambertini, M., Pronzato, P., Genova, C.

Volltext

1517 Emergency department as place of end-of-life care and death in cancer patients von Pronzato, P, Casabona, F, Lambertini, M, Morganti, S, Reggiani, S, Zoli, D, Orengo, G

Volltext

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis von Poggio, F, Ceppi, M, Lambertini, M, Bruzzi, P, Ugolini, D, Bighin, C, Levaggi, A, Giraudi, S, D'Alonzo, A, Vaglica, M, Blondeaux, E, Sertoli, M.R, Pronzato, P, Del Mastro, L., MD

Volltext

Fulvestrant (FUL) as first-line therapy in HR+ve, HER2-ve advanced breast cancer (ABC) patients (pts): when clinical practice comes earlier than clinical trials. Results from the G... von Pronzato, P, Mustacchi, G, Riccardi, F, Turletti, A, Michelotti, A, Natoli, C, Livi, L, Del Mastro, L, Donadio, M, Garrone, O, Giordano, M, De Laurentiis, M, Marchetti, P, Montemurro, F, Romagnoli, E, De Placido, S, Biganzoli, L, Cazzaniga, M

Volltext

5194 POSTER Is the 21-gene Breast Cancer Test (Oncotype DX®) Good Value for Money? von Pronzato, P, Plun-Favreau, J

Volltext

Reply to letter to the editor ‘Primum non nocere’ by Templeton and Šeruga von Aapro, M., Moebus, V., Nitz, U., O'Shaughnessy, J., Pronzato, P., Untch, M., Tomita, D., Bohac, C., Leyland-Jones, B.

Volltext

Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer von Banelli, B., Casciano, I., Di Vinci, A., Gatteschi, B., Levaggi, A., Carli, F., Bighin, C., Salvi, S., Allemanni, G., Ghiorzo, P., Pronzato, P., Venturini, M., Romani, M., Del Mastro, L.

Volltext

First line chemotherapy of metastatic breast cancer von Pronzato, P., Rondini, M.

Volltext

1957 Ovarian suppression with luteinizing hormone-releasing hormone agonists during chemotherapy as a strategy to preserve ovarian function and fertility in breast cancer patients:... von Lambertini, M, Ceppi, M, Poggio, F, Peccatori, F.A, Azim, H.A, Ugolini, D, Pronzato, P, Loibl, S, Moore, H.C.F, Partridge, A.H, Del Mastro, L

Volltext

Hormonotherapy of advanced prostate cancer von Pronzato, P., Rondini, M.

Volltext

1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab von Vaglica, M, Lambertini, M, Ferreira, A, Poggio, F, Puglisi, F, Sottotetti, F, Montemurro, F, Poletto, E, Pozzi, E, Risi, E, Lai, A, Zanardi, E, Sini, V, Ziliani, S, Minuti, G, Mura, S, Grasso, D, Ferrarini, I, Pronzato, P, Del Mastro, L

Volltext

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice von Barni, S., Lorusso, V., Giordano, M., Sogno, G., Gamucci, T., Santoro, A., Passalacqua, R., Iaffaioli, V., Zilembo, N., Mencoboni, M., Roselli, M., Pappagallo, G., Pronzato, P.

Volltext

Breast cancer in elderly women: a different reality? Results from the NORA study von Mustacchi, G, Cazzaniga, ME, Pronzato, P, De Matteis, A, Di Costanzo, F, Floriani, I

Volltext